AI Article Synopsis
- Rabies Immunoglobulins (RIG) are crucial for managing rabies exposures, offering immediate protection until the body's immune response kicks in after vaccination.
- Even though Human Rabies Immune Globulin (HRIG) is the preferred treatment, it can cause rare side effects similar to other biological products.
- A study involving 8,737 patients found that only 0.183% experienced mild, temporary adverse reactions after receiving HRIG.
Article Abstract
Rabies Immunoglobulins (RIG) are an essential part of optimal management of rabies exposures [World Health Organization (WHO)]. They provide protection against the virus during the critical initial 7 days before adequate endogenous vaccine induced antibodies are formed. Even though Human Rabies Immune Globulin (HRIG) is the ideal product for post-exposure rabies treatment it, like most biological, can cause very rare adverse reactions. A retrospective review of a series of 8737 patients, who received HRIG at one institution, revealed that only 15 (0.183 %) reported transient mild adverse reactions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.vaccine.2004.09.013 | DOI Listing |
Publication Analysis
Top Keywords
adverse reactions
12
human rabies
8
rabies immune
8
immune globulin
8
rabies
5
reactions human
4
globulin manufactured
4
manufactured thai
4
thai red
4
red cross
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!